Myriad Genetics (NASDAQ: MYGN) announced an expansion of the Company's collaboration with BioMarin Pharmaceutical Inc (Nasdaq: BMRN). Under the expanded ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE